Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ZLAB
ZLAB logo

ZLAB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Zai Lab Ltd (ZLAB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
23.160
1 Day change
-5.22%
52 Week Range
44.340
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Zai Lab Ltd (ZLAB) is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive technical indicators like MACD and a slight pre-market price increase, the overbought RSI and lack of significant positive catalysts suggest caution. The financial performance shows revenue growth but declining net income and EPS, which raises concerns about profitability. Analyst ratings remain optimistic with 'Overweight' and 'Buy' ratings, but consistent price target reductions signal tempered expectations. Options data indicates bearish sentiment with a high Open Interest Put-Call Ratio. Without strong trading signals or news catalysts, it is better to hold and reassess later.

Technical Analysis

The MACD histogram is positive at 0.41 and expanding, indicating bullish momentum. RSI is at 86.642, signaling the stock is overbought. Moving averages are converging, suggesting indecision in price direction. Key resistance levels are R1: 23.226 and R2: 24.162, while support levels are S1: 20.192 and S2: 19.256.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
6

Positive Catalysts

  • MACD indicates bullish momentum. Pre-market price increased by 0.64%. Analyst ratings remain optimistic with 'Overweight' and 'Buy' ratings.

Neutral/Negative Catalysts

  • RSI indicates overbought conditions. Financial performance shows declining net income and EPS. Analysts have consistently lowered price targets. Options data suggests bearish sentiment with a high Open Interest Put-Call Ratio of 2.14.

Financial Performance

In Q4 2025, revenue increased by 16.99% YoY to $127.6M. However, net income dropped by 38.29% YoY to -$50.4M, and EPS fell by 37.50% YoY to -0.05. Gross margin declined slightly to 60.08%, down 2.17% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain optimistic ratings ('Overweight' and 'Buy'), but price targets have been consistently lowered. The latest price targets range from $32 to $53, reflecting tempered expectations.

Wall Street analysts forecast ZLAB stock price to rise
5 Analyst Rating
Wall Street analysts forecast ZLAB stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 24.440
sliders
Low
25.7
Averages
47.93
High
74
Current: 24.440
sliders
Low
25.7
Averages
47.93
High
74
JPMorgan
Anupam Rama
Overweight
downgrade
$39 -> $32
AI Analysis
2026-03-18
Reason
JPMorgan
Anupam Rama
Price Target
$39 -> $32
AI Analysis
2026-03-18
downgrade
Overweight
Reason
JPMorgan analyst Anupam Rama lowered the firm's price target on Zai Lab to $32 from $39 and keeps an Overweight rating on the shares. The firm updated models in the smid-cap biotechnology space.
Cantor Fitzgerald
Overweight
downgrade
$55 -> $37
2026-02-27
Reason
Cantor Fitzgerald
Price Target
$55 -> $37
2026-02-27
downgrade
Overweight
Reason
Cantor Fitzgerald lowered the firm's price target on Zai Lab to $37 from $55 and keeps an Overweight rating on the shares. Zai Lab reported Q4 and full-year revenues of $127.6M and $460.2M, respectively, in line with consensus, though Vyvgart sales were slightly weaker than expected, the analyst tells investors in a research note. Management indicated that 2026 top-line growth is likely to be modest, with volume gains offset by pricing pressures and competition in China, the firm says.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ZLAB
Unlock Now

People Also Watch